Eliminating drugs from the body is a vital process that occurs through excretion or metabolism. Understanding the kinetics of drug elimination is crucial for drug development, dosage determination, and optimizing patient outcomes.

Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is the half-life of a drug, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order kinetics, where a constant fraction of the drug is eliminated per unit time. This means that as the drug concentration increases, its elimination rate also increases. The relationship between drug concentration and time is exponential.

However, certain drugs, like phenytoin and aspirin, exhibit zero-order kinetics. When administered at high therapeutic doses, these drugs saturate the enzymes responsible for their metabolism. As a result, only a fixed amount of the drug is eliminated at a constant rate, regardless of its concentration. The plot of drug concentration versus time in zero-order kinetics is linear, indicating that increasing the drug concentration does not affect its elimination rate.

Tags
Drug EliminationKineticsDrug ClearancePlasma ConcentrationHalf lifeFirst order KineticsZero order KineticsPhenytoinAspirinMetabolismExcretionDosage DeterminationPatient Outcomes

Aus Kapitel 3:

article

Now Playing

3.24 : Kinetics of Drug Elimination

Pharmacokinetics

3.0K Ansichten

article

3.1 : Pharmakokinetik: Überblick

Pharmacokinetics

3.5K Ansichten

article

3.2 : Absorptionsmechanismus von Medikamenten: Passiver Membrantransport

Pharmacokinetics

3.0K Ansichten

article

3.3 : Absorptionsmechanismus von Medikamenten: Trägervermittelter Membrantransport

Pharmacokinetics

3.0K Ansichten

article

3.4 : Arzneimittelabsorption: Faktoren, die die gastrointestinale Absorption beeinflussen

Pharmacokinetics

3.3K Ansichten

article

3.5 : Bioverfügbarkeit: Überblick

Pharmacokinetics

2.1K Ansichten

article

3.6 : Faktoren, die die Bioverfügbarkeit beeinflussen: First-Pass-Eliminierung

Pharmacokinetics

5.5K Ansichten

article

3.7 : Bioäquivalenz: Überblick

Pharmacokinetics

763 Ansichten

article

3.8 : Effekt "Erster Durchgang"

Pharmacokinetics

4.5K Ansichten

article

3.9 : Zeitverlauf der Arzneimittelwirkung

Pharmacokinetics

1.7K Ansichten

article

3.10 : Wirkstoffverteilung: Gewebebindung

Pharmacokinetics

2.3K Ansichten

article

3.11 : Physiologische Barrieren

Pharmacokinetics

3.1K Ansichten

article

3.12 : Wirkstoffverteilung: Plasmaproteinbindung

Pharmacokinetics

3.1K Ansichten

article

3.13 : Fächermodelle: Modell mit nur einem Fach

Pharmacokinetics

1.9K Ansichten

article

3.14 : Fächermodelle: Modell mit zwei Fächern

Pharmacokinetics

4.6K Ansichten

See More

JoVE Logo

Datenschutz

Nutzungsbedingungen

Richtlinien

Forschung

Lehre

ÜBER JoVE

Copyright © 2025 MyJoVE Corporation. Alle Rechte vorbehalten